-
Lamotrigine
- Inhibits Na channel
- Blocking Glu release
- Indication: Seizures
-
Felbamate
- NMDA antagonist
- Indication: Seizures (decrease excitation)
-
Ketamine
- NMDA antagonist
- Indication: General Anesthetic
-
Memantine
- NMDA antagonist
- Indication: Alzheimer's
-
Vigabatrin
- Inhibits GABA Transaminase
- Indication: Seizures
-
Valproate
- Inhibits GABA Transaminase
- Inhibits succinic semialdehyde dehydrogenase
- Indication: Seizure
-
Benzodiazepines
- Lorazepam
- Diazepam
- Activate GABAA receptor
- Dependent of endogenous GABA
- Indication: Anxiety disorders
-
Barbiturates
- Pentobarbital
- Activates GABAA receptor
- Independent of endogenous GABA
- Indication: Insomnia
-
Tacrine
- Inhibits AchE
- Indication: Alzheimer's
-
Donepezil
- Inhibits AchE
- Indication: Alzheimer's
-
Scopolamine
- Muscarinic Antagonist
- Indication: Motion sickness
-
Varenicline
- a4b2 nicotinic partial agonist
- Indication: Smoking cessation
-
Amphetamine
- Displace vesicular storage of catecholamines
- Indication: Narcolepsy
-
Imipramine
- Block NET (Reuptake)
- Indication: Depression
-
Clorgyline
- MAO-A inhibitor
- Indication: Depression
-
Levodopa
- Dopamine Precursor
- Indication: Parkinson's
-
Ropinirole
- DA receptor agonist
- Indication: Parkinson's
-
Selegiline
- MAO-B inhibitor
- Indication: Parkinson's
-
Tolcapone
- COMT inhibitor
- Indication: Parkinson's
-
Chlorpromazine
- D2 antagonist
- Indication: Psychosis, Nausea, Vomiting
-
Haloperidol
- D2 antagonist
- Indication: Schizophrenia
-
Epinephrine
- Direct agonist
- Indication: Anaphylactic shock
-
Fluoxetine
- SSRI
- Indication: Depression
-
Citalopram
- SSRI
- Indication: Depression
-
Sumatriptan
- 5-HT1B/1D agonist
- Indication: Migraine
-
Buspirone
- 5-HT1A partial agonist
- Indication: Anxiety
-
Ranitidine
- H2 antagonist
- Indication: PUD
-
Diphenhydramine
- H1 antagonist
- Indication: Allergies
-
Meclizine
- H1 antagonist
- Indication: Vertigo
|
|
